Cargando…
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials
IMPORTANCE: The COVID-19 pandemic has caused millions of infections and deaths and resulted in unprecedented international public health social and economic crises. As SARS-CoV-2 spread across the globe and its impact became evident, the development of safe and effective vaccines became a priority....
Autores principales: | Lora, Alfredo J. Mena, Long, Jessica E., Huang, Yunda, Baden, Lindsey R., El Sahly, Hana M., Follmann, Dean, Goepfert, Paul, Gray, Glenda, Grinsztejn, Beatriz, Kotloff, Karen, Rouphael, Nadine, Sobieszczyk, Magdelena, Walsh, Stephen R., Andriesen, Jessica, Shah, Karan A., Zhang, Yuanyuan, Gilbert, Peter, Janes, Holly, Gay, Cynthia L., Falsey, Ann R., Tripp, Rebecca L., Gorman, Richard L., Tong, Tina, Marovich, Mary, Neuzil, Kathleen, Corey, Lawrence, Kublin, James G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546713/ https://www.ncbi.nlm.nih.gov/pubmed/36689221 http://dx.doi.org/10.1001/jamanetworkopen.2022.51974 |
Ejemplares similares
-
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials
por: Theodore, Deborah A., et al.
Publicado: (2023) -
Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials
por: Turley, Christine B., et al.
Publicado: (2023) -
Risk of COVID-19 after natural infection or vaccination
por: Rick, Anne-Marie, et al.
Publicado: (2023) -
1939. Who to Boost When: An Analysis of Dosing Interval and Age on COVID-19 Outcomes in the COVE Trial During the Delta and Omicron Waves
por: Follmann, Dean, et al.
Publicado: (2023) -
Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials
por: Follmann, Dean, et al.
Publicado: (2020)